Live webinar on Wednesday, April 14, 2021 at 5:00PM PT / 8:00PM ET. Hosted in partnership with Abeona Therapeutics, this webinar will provide an overview and update on gene therapy for large chronic wounds in recessive dystrophic epidermolysis bullosa (RDEB), with a presentation from Jean Tang, MD, PhD, Professor of Dermatology, Stanford University Medical Center and Principal Investigator, EB-101 pivotal Phase 3 VIITAL study. There will be a moderated Q&A following the presentation.
Gene Therapy for Large Chronic RDEB Wounds, sponsored by Abeona Therapeutics
Wednesday, April 14, 2021 5:00 PM PT / 8:00 PM ET
Speaker: Jean Tang, MD, PhD
Jean Tang, MD, PhD
Professor of Dermatology, Stanford University Medical Center AND Principal Investigator, EB-101 pivotal Phase 3 VIITAL study. Dr. Tang’s research focuses on genetic skin diseases such as Basal Cell Nevus Syndrome and Epidermolysis Bullosa. She studies new ways to treat and prevent NSMC and melanoma. Dr. Tang has led or co-led the conduct and completion of 6 investigator initiated clinical trials in BCC and EB. She received her MD/PhD from Stanford (Biophysics), completed her dermatology residency at Stanford, and then went to UCSF for a 3 year post-doc in mouse genetics, while simultaneously pursuing formal coursework in biostatistics, epidemiology, and clinical trial design in the KL2 CTSI program.
